Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 416Lymphoma 406Lymphoma, Non-Hodgkin 344Leukemia, Lymphocytic, Chronic, B-Cell 313Lymphoma, Follicular 301Lymphoma, Mantle-Cell 226Lymphoma, B-Cell, Marginal Zone 161Leukemia 119Lymphoma, B-Cell 112Burkitt Lymphoma 110Waldenstrom Macroglobulinemia 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Recurrence 85Hodgkin Disease 60Lymphoma, Large-Cell, Immunoblastic 57Neoplasms 39Multiple Myeloma 26Lymphoma, Large-Cell, Anaplastic 26Myelodysplastic Syndromes 25Leukemia, Myeloid, Acute 24Hematologic Neoplasms 22Dendritic Cell Sarcoma, Interdigitating 22Leukemia, Hairy Cell 20Intraocular Lymphoma 17Leukemia, Prolymphocytic 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, T-Cell 14Neoplasms, Plasma Cell 13Hematologic Diseases 13Lymphoproliferative Disorders 12

Interventions

Doxorubicin 16Zidovudine 13Vincristine 12Bleomycin 11Interferon alpha-2 6Cyclophosphamide 6Methotrexate 5Liposomes 5Leucovorin 5Dexamethasone 5tecogalan 4sargramostim 4Filgrastim 4Etoposide 4Cytarabine 4Ritonavir 3Nivolumab 3Fluorouracil 3pomalidomide 2liposomal doxorubicin 2interferon alfa-n1 2Watchful Waiting 2Valganciclovir 2Tumor Necrosis Factor-alpha 2Tobacco Use Cessation Devices 2Thalidomide 2Surveys and Questionnaires 2Rituximab 2Paclitaxel 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Rituximab × Clear all
NCT00006436 2025-12-30

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
68 enrolled 24 charts
Lymphoid

Acquired Immunodeficiency Syndrome, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related

NCT00267865 2020-06-01

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
12 enrolled 15 charts

Acquired Immunodeficiency Syndrome, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡